Cargando…

ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer

BACKGROUND: Esophageal cancer (ESCA) is one of the most common cancers worldwide and has a very poor prognosis. Hypoxia-inducible factor 1 (HIF1) signaling pathway plays a critical role in tumorigenesis and is therefore considered a potential therapeutic target in the treatment of many cancers. Acti...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Feng, Xiao, Hang, Cai, Yixin, Zhang, Ni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117505/
https://www.ncbi.nlm.nih.gov/pubmed/33980247
http://dx.doi.org/10.1186/s12964-021-00734-x
_version_ 1783691598715944960
author He, Feng
Xiao, Hang
Cai, Yixin
Zhang, Ni
author_facet He, Feng
Xiao, Hang
Cai, Yixin
Zhang, Ni
author_sort He, Feng
collection PubMed
description BACKGROUND: Esophageal cancer (ESCA) is one of the most common cancers worldwide and has a very poor prognosis. Hypoxia-inducible factor 1 (HIF1) signaling pathway plays a critical role in tumorigenesis and is therefore considered a potential therapeutic target in the treatment of many cancers. Activating transcription factor 5 (ATF5) facilitates the expression of various genes and has been extensively studied for its potential role in cancer treatment. METHODS: The expression level of ATF5 in clinic sample was detected by quantitative real time PCR and immunohistochemistry. ATF5 biological function was investigated by western blot, cell cycle analysis, cell viability assay, luciferase reporter assays, colony formation assay, transwell assay, wound healing assay, tube formation assay, and ELISA assay. CHIP and Re-CHIP assay, GST-pulldown, and RNA-sequencing were used to study the cross-talks between ATF5 and HIF1 complex. Mouse xenograft study was utilized to study the correlation of ATF5 and tumor growth in vivo. Student’s t-test or Chi-square test was used for statistical analysis. RESULTS: Here, we first found ATF5 was dramatically upregulated in ESCA cancer and related with poor survival time. Next, we found that the expression level of ATF5 had a positive relationship with the proliferation, migration, and invasion ability of ESCA cells. Besides, we innovatively found that ATF5 functions as a novel coactivator in HIF1 transcription complex by binding to HIF1α. Further, we demonstrated that silencing ATF5 phenocopies HIF1α knockdown in tumorigenic properties in vitro and inhibited ESCA tumor angiogenesis and proliferation in vivo. CONCLUSION: Herein, we found ATF5 as a novel component of the HIF1 transcription complex. The findings of the present study may provide new insights into the development of a novel and more efficient therapeutic strategy against ESCA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-021-00734-x.
format Online
Article
Text
id pubmed-8117505
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81175052021-05-13 ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer He, Feng Xiao, Hang Cai, Yixin Zhang, Ni Cell Commun Signal Research BACKGROUND: Esophageal cancer (ESCA) is one of the most common cancers worldwide and has a very poor prognosis. Hypoxia-inducible factor 1 (HIF1) signaling pathway plays a critical role in tumorigenesis and is therefore considered a potential therapeutic target in the treatment of many cancers. Activating transcription factor 5 (ATF5) facilitates the expression of various genes and has been extensively studied for its potential role in cancer treatment. METHODS: The expression level of ATF5 in clinic sample was detected by quantitative real time PCR and immunohistochemistry. ATF5 biological function was investigated by western blot, cell cycle analysis, cell viability assay, luciferase reporter assays, colony formation assay, transwell assay, wound healing assay, tube formation assay, and ELISA assay. CHIP and Re-CHIP assay, GST-pulldown, and RNA-sequencing were used to study the cross-talks between ATF5 and HIF1 complex. Mouse xenograft study was utilized to study the correlation of ATF5 and tumor growth in vivo. Student’s t-test or Chi-square test was used for statistical analysis. RESULTS: Here, we first found ATF5 was dramatically upregulated in ESCA cancer and related with poor survival time. Next, we found that the expression level of ATF5 had a positive relationship with the proliferation, migration, and invasion ability of ESCA cells. Besides, we innovatively found that ATF5 functions as a novel coactivator in HIF1 transcription complex by binding to HIF1α. Further, we demonstrated that silencing ATF5 phenocopies HIF1α knockdown in tumorigenic properties in vitro and inhibited ESCA tumor angiogenesis and proliferation in vivo. CONCLUSION: Herein, we found ATF5 as a novel component of the HIF1 transcription complex. The findings of the present study may provide new insights into the development of a novel and more efficient therapeutic strategy against ESCA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-021-00734-x. BioMed Central 2021-05-12 /pmc/articles/PMC8117505/ /pubmed/33980247 http://dx.doi.org/10.1186/s12964-021-00734-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
He, Feng
Xiao, Hang
Cai, Yixin
Zhang, Ni
ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer
title ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer
title_full ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer
title_fullStr ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer
title_full_unstemmed ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer
title_short ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer
title_sort atf5 and hif1α cooperatively activate hif1 signaling pathway in esophageal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117505/
https://www.ncbi.nlm.nih.gov/pubmed/33980247
http://dx.doi.org/10.1186/s12964-021-00734-x
work_keys_str_mv AT hefeng atf5andhif1acooperativelyactivatehif1signalingpathwayinesophagealcancer
AT xiaohang atf5andhif1acooperativelyactivatehif1signalingpathwayinesophagealcancer
AT caiyixin atf5andhif1acooperativelyactivatehif1signalingpathwayinesophagealcancer
AT zhangni atf5andhif1acooperativelyactivatehif1signalingpathwayinesophagealcancer